Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

Vol 6, No 2 (2016)

Disorders of urination in patients with chronic pelvic pain syndrome and bladder leukoplakia
Al-Shukri S.H., Kuzmin I.V., Slesarevskaya M.N., Sokolov A.V., Ignashov Y.A.
The study included 177 women with chronic pelvic pain syndrome, among them there were 114 (64.4%) women with bladder leukoplakia which was found by cystoscopy. In comparison these patients to patients without bladder leukoplakia it was noted more sever symptoms of chronic pelvic pain syndrome, such as strong pain, urinary frequency and large smaller average volume urination. This fact must be considered when planning the treatment of patients with chronic pelvic pain syndrome.
Urology reports (St. - Petersburg). 2016;6(2):5-10
Prediction and preclinical diagnosis of the risk of urinary stone formation using biophysical technologies
Goloschapov E.T.
The study involved 836 patients with various forms of urolithiasis, all the patients were undergone by the method of dynamic light scattering particle size of the Tamm-Horsfall protein (THP) in the urine. It was found that the average particle size of the THP urolithiasis patients amounted 1115.95 ± 46.5 nm, whereas only 138.4 ± 7.7 nm in the control group. We think that in patients with urolithiasis change in the electrical properties of the surface THP molecules leads to their agglutination and formation megamolecule complexes which can be the centers of crystallization of oxalate stone formation and one of the factors of the urolithiasis.
Urology reports (St. - Petersburg). 2016;6(2):11-15
Use of Kanefron in treatment of acute uncomplicated cystitis in women
Amdii R.E., Al-Shukri S.H., Kuzmin I.V., Sorokin N.V., Chaplitskii E.A., Skvortsov M.V., Alekseev A.S., Okunchayev A.S., Turbin A.A., Timaeva G.R., Bulaev D.V., Moscaleva Y.S.
The aim of study was to evaluate the efficacy and safety of Kanefron with uncomplicated cystitis in women in clinical practice. Patients and methods. In our work was attended by 22 women with a diagnosis of acute uncomplicated cystitis. The mean age was 29,0 ± 1,8 years (from 19 to 51 years. The criteria of effectiveness were changes in symptoms and laboratory parameters according to the urinary tests at Kanefron monotherapy. Results. After treating by Kanefron there were observed significant improvement in symptoms of acute cystitis. Before treatment the average symptom score was 8,05 ± 0,7 points, on the 3rd day of treatment it significantly decreased to 5,1 ± 1,0 points (p < 0,05) on day 7 of treatment it was up to 2, 9 ± 1,0 points, in the phase of observation of 37 days after initiation of therapy by Kanefron othe average score of symptoms was 0,1 ± 0,3 points. Frequency leukocyturia on the 7 day of treatment according to a study by urine microscopy was 83.3%, and by the 37 th day after the start of Kanefron (phase monitoring) significantly decreased to 37,5% (p < 0,05). Kanefron showed statistically significant antibacterial activity in acute cystitis. Prior to initiating therapy the growth of microorganisms at a titer of more than 100 000 units was detected in 72.7% of patients after 2 weeks of treatment (on day 37 of observation) - in 28,6% of patients (p < 0,05). Conclusions. Our results suggest that Kanefron can be an effective and well-tolerated alternative treatment of uncomplicated infections of the lower urinary tract in women, allowing to reduce the use of antibiotics. Appointment of the drug as a monotherapy Kanefron acute cystitis and duration of treatment requires further study and discussion.
Urology reports (St. - Petersburg). 2016;6(2):16-22
The advantage of the treatment of erectile dysfunction with sildenafil in patients in the late ontogenesis
Didenko V.I.
The aim of the study was to evaluate the benefits and safety of sildenafil in the average patient, elderly with a high degree of comorbidity. This study included patients who applied to the advisory diagnostic center of the Military Medical Academy, they were asked to fill questionnaire MIEF-5 before and after treatment. Total were question questionaired 310 patients in middle age (45-59 years), 90 in the elderly (60-74) and 24 people in old (> 74l). 287 patients were treated by sildenofil. Sildenafil is indicated for patients with erectile dysfunction in elderly and senile patients with comorbidities. If you are using sildenafil, patients have the opportunity not to stop taking essential medicines or to receive if necessary the preparation of the nitrate groups within a short period of time.
Urology reports (St. - Petersburg). 2016;6(2):23-27

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies